| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024270607 |
| P356 | DOI | 10.2165/0023210-200822120-00005 |
| P698 | PubMed publication ID | 18998740 |
| P2093 | author name string | Christian R Dolder | |
| Michael H Nelson | |||
| P2860 | cites work | Amnestic syndrome induced by zoplclone. | Q55066715 |
| Behavioural reactions to triazolam | Q66704788 | ||
| Clonazepam and dopamine-related stereotyped behavior | Q67013925 | ||
| Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics | Q68168429 | ||
| Oxidative metabolism of zolpidem by human liver cytochrome P450S | Q70978034 | ||
| Adverse behavioral effects as manifestations of the major and minor tranquilizers | Q72334110 | ||
| Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole | Q77743592 | ||
| Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction | Q79206120 | ||
| Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms | Q80626292 | ||
| Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol | Q24673617 | ||
| Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial | Q28248824 | ||
| International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function | Q28275171 | ||
| A polysomnographically documented case of adult somnambulism with long-distance automobile driving and frequent nocturnal violence: parasomnia with continuing danger as a noninsane automatism? | Q28279639 | ||
| Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist | Q28306119 | ||
| High dose triazolam and anterograde amnesia | Q28316625 | ||
| Triazolam-Induced Nocturnal Bingeing with Amnesia | Q28321183 | ||
| A fugue-like state associated with diazepam use | Q28378083 | ||
| Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates | Q30854476 | ||
| Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition | Q33834603 | ||
| Central nervous system side effects associated with zolpidem treatment | Q33842608 | ||
| Cytochrome P-450 3A4 and 2C8 are involved in zopiclone metabolism. | Q33872042 | ||
| Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. | Q33902217 | ||
| Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia | Q33914366 | ||
| Ramelteon | Q33991907 | ||
| Melatonin receptors and their regulation: biochemical and structural mechanisms | Q34182743 | ||
| Amnestic sleep-related eating disorder associated with zolpidem | Q34273538 | ||
| Understanding and preventing drug interactions in elderly patients | Q34275547 | ||
| Drug-facilitated robbery or sexual assault: problems associated with amnesia | Q34330315 | ||
| Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists | Q34362926 | ||
| Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications | Q34367180 | ||
| One rare side effect of zolpidem--sleepwalking: a case report | Q34426200 | ||
| Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults | Q34692667 | ||
| The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents | Q35854608 | ||
| TAK-375 Takeda. | Q36022002 | ||
| Tonic for what ails us? high-affinity GABAA receptors and alcohol | Q36094683 | ||
| Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines | Q36884097 | ||
| Adverse behavioral effects of benzodiazepines | Q39175637 | ||
| Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic | Q39459887 | ||
| Benzodiazepine-induced amnesia and anaesthetic practice: a review. | Q39471861 | ||
| Anesthesia and memory processes. | Q39893572 | ||
| The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes | Q41201969 | ||
| Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system | Q42202299 | ||
| Comparative amnestic effects of benzodiazepine hypnotic agents | Q42202416 | ||
| Effect of oral benzodiazepines on memory | Q42241023 | ||
| Amnesia possibly associated with zolpidem administration | Q42553534 | ||
| Behavioral dyscontrol associated with combined use of alprazolam and ethanol | Q42656807 | ||
| Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes | Q44136555 | ||
| Somnambulism Due to Probable Interaction of Valproic Acid and Zolpidem | Q44602389 | ||
| Sleep-walking linked to zolpidem | Q44658557 | ||
| Zaleplon overdose associated with sleepwalking and complex behavior | Q44987694 | ||
| Differential impairment of triazolam and zolpidem clearance by ritonavir | Q45285930 | ||
| Drug-facilitated sexual assault and analytical toxicology: the role of LC-MS/MS A case involving zolpidem | Q46374280 | ||
| Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients | Q46769394 | ||
| Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia | Q46908013 | ||
| Triazolam and zolpidem: effects on human memory and attentional processes | Q48179475 | ||
| Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem | Q48330657 | ||
| Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine | Q48471344 | ||
| Compulsive activity and anterograde amnesia after zolpidem use. | Q48474516 | ||
| Dependence on zolpidem | Q48474625 | ||
| Factors influencing midazolam hydroxylation activity in human liver microsomes | Q48705097 | ||
| Zolpidem tartrate and somnambulism | Q48743448 | ||
| Sedative, memory, and performance effects of hypnotics | Q48832114 | ||
| A case of parasomnia at REM sleep onset | Q48971030 | ||
| Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. | Q51365751 | ||
| Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Q51434685 | ||
| Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses. | Q51833723 | ||
| Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. | Q52036594 | ||
| Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo. | Q52051508 | ||
| Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands. | Q52168916 | ||
| Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder. | Q54193601 | ||
| Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. | Q54576089 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1021-1036 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Hypnosedative-induced complex behaviours : incidence, mechanisms and management | |
| P478 | volume | 22 |
| Q37104407 | A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patients |
| Q37979871 | A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia |
| Q64985195 | An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics. |
| Q36526428 | Association between GABA(A) receptor subunit gene cluster and zolpidem-induced complex sleep behaviors in Han Chinese. |
| Q37577869 | Comparative tolerability of newer agents for insomnia |
| Q42926952 | Darwin's Predisposition and the Restlessness that Drives Sleepwalking |
| Q41896124 | Eszopiclone-induced Parasomnia with Suicide Attempt: A Case Report |
| Q37599340 | Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness. |
| Q33615826 | Good night and good luck: norepinephrine in sleep pharmacology |
| Q34257362 | Hypnotics' association with mortality or cancer: a matched cohort study |
| Q26861336 | In the Zzz zone: the effects of Z-drugs on human performance and driving |
| Q35881636 | Is Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan |
| Q64977051 | Jet lag: Heuristics and therapeutics. |
| Q37450164 | Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon |
| Q88649577 | NREM parasomnias: a treatment approach based upon a retrospective case series of 512 patients |
| Q37510465 | National use of prescription medications for insomnia: NHANES 1999-2010. |
| Q30526455 | Parasomnias: an updated review |
| Q37802485 | Pathologies of awakenings: the clinical problem of insomnia considered from multiple theory levels |
| Q35160989 | Persistent psychosis after abuse of high dose of zolpidem |
| Q26785474 | Prescription Sedative Misuse and Abuse |
| Q39251880 | Prevalence and clinical correlates of flunitrazepam-related complex sleep behaviors |
| Q35187003 | Prevalence and factors associated with off-label antidepressant prescriptions for insomnia |
| Q39324215 | Psychiatric Illness and Parasomnias: a Systematic Review |
| Q59125668 | Recorded atypical hallucinations in psychotic and affective disorders and associations with non-benzodiazepine hypnotic use: the South London and Maudsley Case Register |
| Q48123271 | Restless Eating, Restless Legs, and Sleep Related Eating Disorder |
| Q36123791 | Restless nocturnal eating: a common feature of Willis-Ekbom Syndrome (RLS) |
| Q41146827 | Reversal of a Suspected Paradoxical Reaction to Zopiclone with Flumazenil. |
| Q34233363 | Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. |
| Q48228995 | Sleep and violence |
| Q48110715 | Sleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour |
| Q38286225 | Sleep-related eating disorder and its associated conditions |
| Q47887775 | Sleepwalking |
| Q48318293 | Sleepwalking in Parkinson's disease: a questionnaire-based survey |
| Q37782022 | Sleepwalking, A Possible Side Effect of Antipsychotic Medication |
| Q41909276 | Sodium oxybate-induced sleep driving and sleep-related eating disorder |
| Q44123921 | Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008. |
| Q30362407 | The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. |
| Q34327511 | The clinical and forensic toxicology of Z-drugs. |
| Q37535058 | The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats |
| Q36165434 | Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic Approaches |
| Q30380550 | Treatment of nocturnal eating disorders. |
| Q36419763 | Two cases of zolpidem-associated homicide |
| Q37815339 | Violence in sleep |
| Q42371902 | Zolpidem Induced Sleep-related Eating and Complex Behaviors in a Patient with Obstructive Sleep Apnea and Restless Legs Syndrome |
| Q37994346 | Zolpidem for insomnia |
| Q35583074 | Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series |
| Q42851391 | Zolpidem-induced sleep-related behavioural disorders |
Search more.